Brief: Sprint Bioscience Gets Proceeds Of About SEK 37.9 Mln Before Issue Costs In Rights Issue
March 9 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* GETS PROCEEDS OF ABOUT SEK 37.9 MILLION BEFORE ISSUE COSTS
IN
RIGHTS ISSUE
* UPON FULL EXERCISE OF WARRANTS, CO GETS FURTHER PROCEEDS
OF
BETWEEN SEK 25.2-48.8 MILLION BEFORE ISSUE COSTS DURING Q1 2019
Source text for Eikon: ID:nWkrXdcBx
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln